Recommandations 2020 de la Société française de rhumatologie pour la prise en charge de la goutte: traitement des crises de goutte

A Latourte, T Pascart, RM Flipo, G Chalès… - Revue du …, 2020 - Elsevier
Objectif Élaborer les recommandations de la Société française de rhumatologie pour la prise
en charge des crises de goutte. Méthodes Ces recommandations ont été élaborées par 9 …

Recommandations françaises 2020 sur la prise en charge des arthrites septiques sur articulation native de l'adulte

…, R Touitou, B Fouquet, D Mulleman, RM Flipo… - Revue du …, 2020 - Elsevier
L’arthrite septique (AS) sur articulation native de l’adulte est une affection rare mais qui
constitue une urgence diagnostique en raison de la morbi-mortalité et du risque fonctionnel …

[HTML][HTML] COVID-19 outcomes in patients with inflammatory rheumatic and musculoskeletal diseases treated with rituximab: a cohort study

…, B Fautrel, J Pouchot, T Thomas, RM Flipo… - The Lancet …, 2021 - thelancet.com
Background Various observations have suggested that the course of COVID-19 might be
less favourable in patients with inflammatory rheumatic and musculoskeletal diseases …

Lack of placental transfer of certolizumab pegol during pregnancy: results from CRIB, a prospective, postmarketing, pharmacokinetic study

…, B Abraham, AD Flynn, A Moltó, RM Flipo… - Annals of the …, 2018 - ard.bmj.com
Objectives There is a need for effective and safe treatment during pregnancy in women with
chronic inflammatory diseases. This study evaluated placental transfer of certolizumab pegol …

[HTML][HTML] MUC5B Promoter Variant and Rheumatoid Arthritis with Interstitial Lung Disease

…, B Wallaert, RM Flipo… - … England Journal of …, 2018 - Mass Medical Soc
Background Given the phenotypic similarities between rheumatoid arthritis (RA)–associated
interstitial lung disease (ILD) (hereafter, RA-ILD) and idiopathic pulmonary fibrosis, we …

[HTML][HTML] Associations of baseline use of biologic or targeted synthetic DMARDs with COVID-19 severity in rheumatoid arthritis: results from the COVID-19 Global …

…, CA Scirè, B Raffeiner, T Thomas, RM Flipo… - Annals of the …, 2021 - ard.bmj.com
Objective To investigate baseline use of biologic or targeted synthetic (b/ts) disease-modifying
antirheumatic drugs (DMARDs) and COVID-19 outcomes in rheumatoid arthritis (RA). …

Prevalence of rheumatoid arthritis in France: 2001

…, L Euller-Ziegler, RM Flipo… - Annals of the …, 2005 - ard.bmj.com
Background: Prevalence estimates of rheumatoid arthritis (RA) vary across Europe. Recent
estimates in southern European countries showed a lower prevalence than in northern …

Prevalence of spondyloarthropathies in France: 2001

…, L Euller-Ziegler, RM Flipo… - Annals of the …, 2005 - ard.bmj.com
Objective: To estimate the prevalence of spondyloarthropathies (SpAs) in France in a
multiregional representative sample in the year 2001. Methods: A two stage random sample was …

Association between tumor necrosis factor inhibitors and the risk of hospitalization or death among patients with immune-mediated inflammatory disease and COVID …

…, CDL Marques, AM Kakehasi, RM Flipo… - JAMA network …, 2021 - jamanetwork.com
Importance Although tumor necrosis factor (TNF) inhibitors are widely prescribed globally
because of their ability to ameliorate shared immune pathways across immune-mediated …

Suggestions for managing pyogenic (non-tuberculous) discitis in adults

F Grados, FX Lescure, E Senneville, RM Flipo… - Joint Bone Spine, 2007 - Elsevier
OBJECTIVES: To develop recommendations about identifying the causative organism,
obtaining imaging studies, and selecting pharmacological and non-pharmacological treatments …